GRK2 is an endogenous protein inhibitor of the insulin signaling pathway for glucose transport stimulation

The EMBO Journal
Isao UsuiJerrold M Olefsky

Abstract

G protein-coupled receptor kinases (GRKs) represent a class of proteins that classically phosphorylate agonist-activated G protein-coupled receptors, leading to uncoupling of the receptor from further G protein activation. Recently, we have reported that the heterotrimeric G protein alpha-subunit, Galphaq/11, can mediate insulin-stimulated glucose transport. GRK2 contains a regulator of G protein signaling (RGS) domain with specificity for Galphaq/11. Therefore, we postulated that GRK2 could be an inhibitor of the insulin signaling cascade leading to glucose transport in 3T3-L1 adipocytes. In this study, we demonstrate that microinjection of anti-GRK2 antibody or siRNA against GRK2 increased insulin-stimulated insulin-responsive glucose transporter 4 (GLUT4) translocation, while adenovirus-mediated overexpression of wild-type or kinase-deficient GRK2 inhibited insulin-stimulated GLUT4 translocation as well as 2-deoxyglucose uptake. Importantly, a mutant GRK2 lacking the RGS domain was without effect. Taken together, these results indicate that through its RGS domain endogenous GRK2 functions as a negative regulator of insulin-stimulated glucose transport by interfering with Galphaq/11 signaling to GLUT4 translocation. Furthermo...Continue Reading

References

Mar 1, 1980·The Journal of Clinical Investigation·D C Deibert, R A DeFronzo
Jan 12, 1996·The Journal of Biological Chemistry·K BaltenspergerC C Malbon
Feb 1, 1996·Current Biology : CB·D P SiderovskiM Tyers
Apr 1, 1997·Journal of Molecular Medicine : Official Organ of the Gesellschaft Deutscher Naturforscher Und Ärzte·J F ChenC C Malbon
Oct 6, 1998·Annual Review of Biochemistry·J A PitcherR J Lefkowitz
May 13, 1999·Proceedings of the National Academy of Sciences of the United States of America·F DickerM J Lohse
Sep 22, 1999·Molecular and Cellular Biology·T ImamuraJ M Olefsky
Nov 24, 1999·The Journal of Biological Chemistry·C V CarmanT Kozasa
Mar 4, 2000·Proceedings of the National Academy of Sciences of the United States of America·K L PierceR J Lefkowitz
Feb 28, 2001·Proceedings of the National Academy of Sciences of the United States of America·L M LuttrellR J Lefkowitz
Mar 30, 2001·The Journal of Biological Chemistry·S DalleJ M Olefsky
Aug 14, 2001·The Journal of Biological Chemistry·J TaoH Y Wang
Jan 26, 2002·The Journal of Biological Chemistry·Sergey DoroninCraig C Malbon
Sep 5, 2002·Nature Reviews. Molecular Cell Biology·Kristen L PierceRobert J Lefkowitz
Dec 19, 2002·Molecular Pharmacology·Trudy A Kohout, Robert J Lefkowitz
Jan 2, 2003·Proceedings of the National Academy of Sciences of the United States of America·Christopher J HupfeldJerrold M Olefsky
Feb 5, 2003·The Journal of Biological Chemistry·Isao UsuiJerrold M Olefsky

❮ Previous
Next ❯

Citations

Jun 9, 2009·Proceedings of the National Academy of Sciences of the United States of America·Xi JiangLan Ma
Sep 28, 2006·Annual Review of Physiology·Christopher J Hupfeld, Jerrold M Olefsky
Jul 23, 2011·Circulation Research·Stephen L Belmonte, Burns C Blaxall
Jul 6, 2006·Clinical and Experimental Hypertension : CHE·Mohammad Asghar, Mustafa F Lokhandwala
May 28, 2011·Archives of Physiology and Biochemistry·Federico MayorCristina Murga
Dec 4, 2014·Growth Hormone & IGF Research : Official Journal of the Growth Hormone Research Society and the International IGF Research Society·Caitrin CruddenLeonard Girnita
Oct 9, 2015·Journal of Smooth Muscle Research = Nihon Heikatsukin Gakkai Kikanshi·Kumiko TaguchiTsuneo Kobayashi
Nov 1, 2012·Biochemical and Biophysical Research Communications·Li WangLan Ma
Oct 16, 2012·Trends in Cardiovascular Medicine·Fadia A KamalBurns C Blaxall
Jan 27, 2012·Trends in Pharmacological Sciences·Tama EvronMarc G Caron
Oct 11, 2011·Cellular Signalling·Anna FuscoGuido Iaccarino
Sep 10, 2011·Pharmacology & Therapeutics·Eugenia V GurevichVsevolod V Gurevich
Jul 22, 2008·Chemical Biology & Drug Design·Rebecca A RoofHenry I Mosberg
Apr 25, 2006·Chemical Biology & Drug Design·Rebecca A RoofRichard R Neubig
Mar 6, 2013·Journal of Cellular Physiology·Zhengyu WeiCataldo Doria
Sep 3, 2011·British Journal of Pharmacology·Nodi DehvariTore Bengtsson
Apr 18, 2012·Biochemical and Biophysical Research Communications·Feifei WangLan Ma
May 15, 2016·Pharmacological Research : the Official Journal of the Italian Pharmacological Society·Eugenia V GurevichVsevolod V Gurevich
Jul 1, 2016·Journal of Medicinal Chemistry·Manuela GuccioneSilvana Grasso
Dec 31, 2016·Biomolecules & Therapeutics·Supachoke MangmoolHitoshi Kurose
Mar 23, 2017·Journal of Cardiovascular Pharmacology·Sarah M Schumacher, Walter J Koch
Jan 10, 2019·International Journal of Molecular Sciences·Qi-Yuan HuangLi-Xia Xiong
Sep 27, 2005·Physiological Reviews·Nina Wettschureck, Stefan Offermanns
Aug 1, 2007·The Journal of Biological Chemistry·Yuji KawamataJerrold M Olefsky
Feb 22, 2012·Molecular Biology Reports·Feng-Ling WangWei Wei
Nov 30, 2016·Molecular Pharmacology·Laura NoguésFederico Mayor
Apr 3, 2015·Physiological Reviews·Priscila Y SatoWalter J Koch
Jul 4, 2019·American Journal of Physiology. Cell Physiology·Leandro Henrique ManfrediCraig McFarlane
Apr 21, 2012·FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology·Rocio Vila-BedmarSonia Fernández-Veledo
Oct 22, 2005·The Journal of Biological Chemistry·Jie HuangJerrold M Olefsky
Apr 10, 2018·Nihon yakurigaku zasshi. Folia pharmacologica Japonica·Takahiro HorinouchiSoichi Miwa

❮ Previous
Next ❯

Related Concepts

Related Feeds

AKT Pathway

This feed focuses on the AKT serine/threonine kinase, which is an important signaling pathway involved in processes such as glucose metabolism and cell survival.